Delivery Device Patents on GLP-1 Receptor Agonists

被引：0
|
作者：
Alhiary, Rasha [1 ]
Gabriele, Sarah [1 ]
Kesselheim, Aaron S. [1 ]
Tu, S. Sean [2 ]
Feldman, William B. [1 ]
机构：
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA
[2] West Virginia Univ, Coll Law, Morgantown, WV USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 331卷 / 09期
关键词：
D O I：
10.1001/jama.2024.0919
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This study analyzed the US Food and Drug Administration-listed patents on glucagon-like peptide 1 (GLP-1) receptor agonists to determine their claim characteristics and the potential barriers they pose to generic entry.
引用
收藏
页码：794 / 796
页数：3
相关论文
共 50 条
  • [41] GLP-1 Receptor Agonists and Gastrointestinal Adverse Events
    Suissa, Karine
    Cromer, Sara J.
    Patorno, Elisabetta
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (10):
  • [42] Is cardioprotection with GLP-1 receptor agonists a class effect?
    Ryden, Lars
    Ferrannini, Giulia
    Mellbin, Linda
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 28 (01) : 18 - 21
  • [43] Two New GLP-1 Receptor Agonists for Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 109 - 111
  • [44] GLP-1 receptor agonists beyond diabetes management
    不详
    ECLINICALMEDICINE, 2024, 78
  • [45] GLP-1 Receptor Agonists in Diabetic Kidney Disease
    Michos, Erin D.
    Tuttle, Katherine R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (10): : 1578 - 1580
  • [46] The potential role of GLP-1 receptor agonists in osteoarthritis
    Ryan, Mackenzie
    Megyeri, Saige
    Nuffer, Wes
    Trujillo, Jennifer M.
    PHARMACOTHERAPY, 2025, 45 (03): : 177 - 186
  • [47] GLP-1 receptor agonists, carotid atherosclerosis and retinopathy
    Rizzo, Manfredi
    Nikolic, Dragana
    Di Pace, Francesco
    Papanas, Nikolaos
    Montano, Nicola
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (12) : 1163 - 1165
  • [48] GLP-1 receptor agonists: differentiation within the class
    Taylor, Simeon I.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (02): : 83 - 85
  • [49] GLP-1 receptor agonists: new treatment frontiers
    不详
    NATURE MENTAL HEALTH, 2025, 3 (03): : 267 - 268
  • [50] GLP-1 receptor agonists: a magic bullet for obesity?
    不详
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2024, 51
12345